226
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

, ORCID Icon, , , , & show all
Pages 661-665 | Received 06 Apr 2023, Accepted 14 Jun 2023, Published online: 24 Jun 2023

References

  • Holmes J, McGarvey LP, Birring SS, Fletcher H, Heaney LG. An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma. Eur Respir J. 2022;60(6):2103205. doi:10.1183/13993003.03205-2021
  • Côté A, Russell RJ, Boulet LP, et al. Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST guideline and expert panel report. Chest. 2020;158(1):68–96. doi:10.1016/j.chest.2019.12.021
  • Fukumitsu K, Kanemitsu Y, Asano T, et al. Tiotropium attenuates refractory cough and capsaicin cough reflex sensitivity in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(5):1613–1620.e1612. doi:10.1016/j.jaip.2018.01.016
  • Laforest L, Van Ganse E, Devouassoux G, et al. Dispensing of antibiotics, antitussives and mucolytics to asthma patients: a pharmacy-based observational survey. Respir Med. 2008;102(1):57–63. doi:10.1016/j.rmed.2007.08.004
  • Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108(2):184–190. doi:10.1067/mai.2001.117880
  • Hanania NA, Alpan O, Hamilos DL, et al. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med. 2011;154(9):573–582. doi:10.7326/0003-4819-154-9-201105030-00002
  • MacDonald KM, Kavati A, Ortiz B, Alhossan A, Lee CS, Abraham I. Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018. Expert Rev Clin Immunol. 2019;15(5):553–569. doi:10.1080/1744666X.2019.1574571
  • Van Ganse E, Van der Linden P, Leufkens HG, Vincken W, Ernst P. Antiallergic and antitussive medications: extent of use and relationship to asthma exacerbations. Therapie. 1996;51(4):373–377.
  • Holmes J, Heaney LG, McGarvey LPA. Objective and subjective measurement of cough in asthma: a systematic review of the literature. Lung. 2022;200(2):169–178. doi:10.1007/s00408-022-00527-0
  • Diab N, Patel M, O’Byrne P, Satia I. Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis. Lung. 2022;200(6):707–716. doi:10.1007/s00408-022-00575-6
  • Watelet JB, Van Zele T, Brusselle G. Chronic cough in upper airway diseases. Respir Med. 2010;104(5):652–657. doi:10.1016/j.rmed.2009.11.020
  • Prenner B, Topp R, Beltyukova S, Fox C. Referrals, etiology, prevalence, symptoms, and treatments of chronic cough: a survey of allergy specialists. Ann Allergy Asthma Immunol. 2022;129(6):731–736. doi:10.1016/j.anai.2022.08.993
  • Turner RD, Birring SS. Measuring cough: what really matters? J Thorac Dis. 2023;15(4):2288–2299. doi:10.21037/jtd-23-230
  • Lam SHF, Homme J, Avarello J, et al. Use of antitussive medications in acute cough in young children. J Am Coll Emerg Physicians Open. 2021;2(3):e12467. doi:10.1002/emp2.12467
  • De Blasio F, Virchow JC, Polverino M, et al. Cough management: a practical approach. Cough. 2011;7(1):7. doi:10.1186/1745-9974-7-7